| Value | ₹64.00 Cr |
|---|
BSE filing, NSE: INDOCO. Summary written from the filing by ALFA Finder's alert engine.
Indoco Remedies Ltd: key numbers
- Share price
- ₹209.50
- Market cap
- ₹1,934 Cr
- Revenue (annual)
- ₹1,845 Cr
- Net profit (annual)
- ₹-95.14 Cr
- P/E (TTM)
- 60.5×Sector 48.7×
- Promoter holding
- 58.92%+0.06% QoQ
- FII holding
- 1.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indoco Remedies Ltd
All →Indoco Remedies Earnings Call Transcript: Key Takeaways
Indoco Remedies hit record quarterly revenue exceeding ₹500 Cr, but faced margin compression from elevated geopolitical freight and material costs.
- Call
- Guides 10% growth
Indoco Remedies Business Update
Indoco's CRO AnaCipher received ANVISA Brazil approval for clinical and bioanalytical facilities. This expands its regulatory footprint to conduct bioequivalence studies in Brazil and Latin America.
Indoco Remedies Q2 FY27 Results: Turns Profitable, Net Profit ₹19.5 Cr
Indoco Remedies Ltd reported revenue from operations of ₹506.9 Cr (+7.4% YoY) and net profit of ₹19.5 Cr for Q2 FY27.
- Key figure
- Net profit ₹19.5 Cr
Indoco Remedies Employee Stock Options
Indoco Remedies allotted 14,850 ESOP shares to its Employees Welfare Trust under the 2022 ESOP plan. The allotment is at face value with no transaction price.
Indoco Remedies Other Announcement
Indoco Remedies Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in accordance with SEBI Regulation 31(1)(b).
Indoco Remedies Board Meeting Date
Indoco Remedies intimated a board meeting on 27 Oct 2026 to approve Q1 FY27 standalone and consolidated results. Trading window remains closed until 29 Oct 2026.
Other business update announcements
All →Rubicon Research Business Update
Rubicon Research disclosed a USFDA inspection of its Ambernath facility, which issued five procedural Form 483 observations. No monetary penalty or amount is involved.
Studio LSD Business Update
Studio LSD Limited provided a business update for Q2 FY27, highlighting operational milestones in television episode counts, OTT series production, theatrical film releases, and music catalogue licensing.
Gujarat Alkalies & Chemicals Business Update
Gujarat Alkalies reported that 6.6 MW of its 75.9 MW Clean Max hybrid power project is now operative. The project is in stabilisation, and the remaining supply will follow in due course.
- hybrid power capacity operative
- 6.6 MW
Clean Science & Technology Business Update
Clean Science's subsidiary Clean Fino-Chem completed product trials for advanced HALS grades developed with Geneus Chem AG. Commercial launch of the new range is expected in H2 FY2026-27.
PI Industries Business Update
PI Industries unveiled Pioxaniliprole, India's first indigenously discovered insecticide molecule, which has received CIB&RC registration. The press release marks a milestone in the company's original crop-protection research.
Karbonsteel Engineering Business Update
Karbonsteel Engineering exhibited at two October 2026 trade fairs, India Industrial Fair and Steel Construction Expo Asia. No order, contract or financial figure was disclosed.